|
|
||||||||
The Journal of Immunology, Vol 147, Issue 10 3268-3273, Copyright © 1991 by American Association of Immunologists
ARTICLES |
XM Gao, B Zheng, FY Liew, S Brett and J Tite
Department of Cell Biology, Wellcome Research Labs, Beckenham, Kent, U.K.
Influenza virus-specific CTL were primed in vivo by immunization with short synthetic peptides representing major CTL epitopes from the nucleoprotein of type A influenza virus. The resultant CTL after in vitro boosting of primed spleen cells recognized both virus-infected and peptide-pulsed target cells. The requirement of CD4+ T cell activation was investigated in several ways. First the addition of helper epitopes to the CTL epitope did not enhance CTL generation, suggesting that helper activity was either not limiting or not required. However, in vivo depletion of CD4+ T cells completely inhibited the generation of CTL by peptide immunization. The inclusion of anti-CD4 in the in vitro restimulation with peptide also prevented the generation of CTL, whereas in vitro reactivation of virus immune spleen cells with peptide was not inhibited by anti-CD4. Thus there appears to be heterogeneity in the requirement of CD4+ T cell proliferation in CTL generation. One possibility is that virus infected cells can stimulate higher affinity T cells that are less helper T cell dependent.
This article has been cited by other articles:
![]() |
M. S. Bijker, S. J. F. van den Eeden, K. L. Franken, C. J. M. Melief, R. Offringa, and S. H. van der Burg CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund's Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity J. Immunol., October 15, 2007; 179(8): 5033 - 5040. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deliyannis, D. C. Jackson, N. J. Ede, W. Zeng, I. Hourdakis, E. Sakabetis, and L. E. Brown Induction of Long-Term Memory CD8+ T Cells for Recall of Viral Clearing Responses against Influenza Virus J. Virol., March 27, 2002; 76(9): 4212 - 4221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wallin, L. Liang, A. Bakardjiev, and W. C. Sha Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation J. Immunol., July 1, 2001; 167(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Muderspach, S. Wilczynski, L. Roman, L. Bade, J. Felix, L. A. Small, W. M. Kast, G. Fascio, V. Marty, and J. Weber A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive Clin. Cancer Res., September 1, 2000; 6(9): 3406 - 3416. [Abstract] [Full Text] |
||||
![]() |
C. Sedlik, G. Dadaglio, M. F. Saron, E. Deriaud, M. Rojas, S. I. Casal, and C. Leclerc In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity J. Virol., July 1, 2000; 74(13): 5769 - 5775. [Abstract] [Full Text] |
||||
![]() |
A. L.-D. de Cerio, N. Casares, J. J. Lasarte, P. Sarobe, L. A. Perez-Mediavilla, M. Ruiz, J. Prieto, and F. Borras-Cuesta Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides Int. Immunol., December 1, 1999; 11(12): 2025 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Harling-McNabb, G. Deliyannis, D. C. Jackson, S. Gerondakis, G. Grigoriadis, and L. E. Brown Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response Int. Immunol., September 1, 1999; 11(9): 1431 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Moskophidis and D. Kioussis Contribution of Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model J. Exp. Med., July 20, 1998; 188(2): 223 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Zheng, S. Brett, J. Tite, M. Lifely, T. Brodie, and J Rhodes Galactose oxidation in the design of immunogenic vaccines Science, June 12, 1992; 256(5063): 1560 - 1563. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |